PRP for Fertility
Updated: Jul 28
PRP has become one of the most talked-about “advanced” fertility treatments, especially among women with low ovarian reserve or recurrent transfer failures.
Depending on which clinic you talk to, PRP is either a revolutionary breakthrough, a promising experimental therapy or a very expensive fad with limited data.
The truth sits somewhere in the middle.
Let’s look at what PRP is, how it works, and when it might (or might not) help.
What Is PRP?
PRP stands for platelet-rich plasma.
It's made by taking a small tube of your blood and spinning it in a centrifuge, then separating out a layer rich in growth factors and injecting that layer into the ovaries or uterus.
These growth factors can stimulate healing, improve blood flow, reduce inflammation, and encourage tissue regeneration, which is why PRP is used in orthopaedics, hair growth, dentistry, and sports injuries.
Fertility clinics have adapted the concept for the ovaries and uterus.
1. Ovarian PRP
Regular PRP

PRP is injected directly into the ovaries via a procedure similar to egg collection.
The idea is that the growth factors may stimulate:
Ovarian stem cells
Follicle growth
Improved egg quality
Increased antral follicle count
Improved hormone levels (AMH)
Who it is marketed toward
It's marketed toward women with low AMH, women over 40, women with poor response, premature ovarian insufficiency, and women wanting more eggs for PGT-A.
The science
A few small studies show(1),(2),(3),(4) a slight increase in AFC, AMH and occasional spontaneous follicles appearing with possible improvements in response next cycle
Regular PRP has seen the biggest improvements for younger women with premature ovarian failure(5).
But there are no large controlled trials, results are unpredictable, benefits vary wildly between women, many see no improvement, and it does not turn back the clock.
I spoke to many women who did ovarian PRP and results were mixed. Some saw results the next month, others in 3 months. And the results tended to last up to 6 months.
Does ovarian PRP improve live birth rates?
We do not know yet.
Evidence is promising but early.
Some doctors say it “reverses menopause” or “restores fertility”. Others don’t believe in it. The first one I did in Belgium, the doctor there told me women were doing it to temporarily come out of early menopause to alleviate the side effects.
Risks
The cost is high and you may experience some discomfort. Also there is no guarantee of it working.
Who might genuinely benefit
Women with previous cycles where follicles failed to grow
Poor responders who have tried multiple protocols
Women who want to try every option before donor eggs
Women with POI (responders vary but some small successes exist)
Who probably won’t benefit
Women with normal ovarian reserve
First-time IVF patients
People expecting huge changes in egg numbers
Ovarian PRP is a last-resort / experimental option - not a standard treatment.
2. Adipose PRP
Adipose PRP - sometimes called fat-derived PRP, adipose-derived PRP, or loosely grouped with adipose-derived stem cell therapy - is an emerging treatment being explored in fertility medicine, particularly for poor ovarian reserve, premature ovarian insufficiency, and refractory endometrial issues.
It tends to sit firmly in the experimental category, and it’s important to understand exactly what it is - and what it isn’t - before considering it.
What Is Adipose PRP?
Adipose PRP uses fat tissue (adipose tissue) rather than blood as the source material.
The process usually involves:
Liposuction-style fat collection (often from the abdomen or thighs)
Processing the fat to isolate:
Platelet-rich plasma
Growth factors
Stromal vascular fraction (SVF), which contains:
Adipose-derived mesenchymal stem cells (ADSCs)
Immune cells
Endothelial and progenitor cells
Injection of the processed material into:
The ovaries, or
The uterus, depending on indication
The theory is that adipose tissue contains a higher concentration of regenerative cells and growth factors than blood-derived PRP alone. But it is often combined with PRP before being injected into the ovaries.
Why Adipose PRP Is Being Explored in Fertility
Adipose tissue is biologically active. Compared with blood PRP, it contains:
Higher numbers of mesenchymal stem cells
Angiogenic growth factors (VEGF, PDGF)
Anti-inflammatory cytokines
Factors involved in tissue repair and regeneration
This has led to interest in whether adipose PRP might stimulate ovarian tissue regeneration, improve ovarian blood flow, activate dormant follicles or enhance endometrial repair and receptivity
Importantly, this is based on biological plausibility, not definitive clinical proof.
Adipose PRP for Ovarian Function
Proposed Benefits (Theoretical + Early Clinical Observations)
Small observational studies and case series suggest adipose-derived therapies may(6)(7)(8)
Increase AMH levels in some women
Increase AFC
Lead to spontaneous follicular development
Restore menstrual cycles in some POI patients
Result in occasional spontaneous or IVF pregnancies
Because adipose tissue contains stem-cell-like populations, the hypothesis is that it may:
Reduce ovarian inflammation
Improve ovarian micro-vascularisation
Promote follicular activation pathways
However, these findings are not yet supported by large randomised controlled trials.
What the evidence actually looks like - most studies are small and uncontrolled. And conducted with highly selective patients.
Many combine adipose PRP with other interventions, making it hard to isolate effect.
Outcomes are often reported as before vs after, not against a matched control group.
Some reviews note:
Increases in ovarian reserve markers in subsets of patients
Highly variable response
No reliable way to predict who will benefit
At present, no major fertility society recommends adipose PRP as standard care. I did it on my ovaries and definitely saw an improvement but everyone is different.
3. Endometrial PRP

Endometrial PRP is more widely accepted and supported than ovarian PRP.
PRP is injected into the uterus to try to improve lining thickness, blood flow, receptivity, and endometrial health.
Who it is used for
It's used for women with chronically thin lining, lining that won't grow despite oestrogen, Asherman's syndrome (scarring), multiple failed transfers, endometritis recovery, or poor blood flow to the uterus.
The science
Compared to ovarian PRP, endometrial PRP has more studies, clearer benefits and better clinical success stories
Studies show(9)(10)(11)
Increased lining thickness
Better trilaminar appearance
Higher implantation rates in thin-lining patients
Improved pregnancy outcomes in repeated failures
Not a miracle, but promising and often worth trying.
How it’s done
A small catheter is used (similar to an embryo transfer)
PRP is infused into the lining
Usually done 2–3 times in a cycle
Risks - mild cramping, spotting, infection
Best candidates
Women whose lining never gets above 6-7mm, women with scarring or past D&C trauma, multiple failed FETs with good embryos, a chronic endometritis history, or poor blood flow.
This is one of the few add-ons where real improvement can be seen in difficult cases.
Does PRP improve egg quality?
Let’s be honest:
We do not yet have strong evidence that ovarian PRP improves egg quality in the way people think.
It may improve follicle recruitment, ovarian environment or hormonal profiles. But there is no proof it changes the internal genetics of the egg.
Some women get more eggs after PRP. Some get the same. Some get none.
It is not guaranteed, but it can be a meaningful option for women with very limited choices.
Costs

Varies widely:
Ovarian PRP: £800–£3,000+
Endometrial PRP: £300–£900 per infusion
Choose clinics with experience - results depend hugely on technique and timing.
Summary
Ovarian PRP: experimental, may help some poor responders, evidence is early and mixed, not a miracle, should be considered only after personalised protocols have been tried.
Endometrial PRP: more evidence, useful for thin lining and repeated failure, can genuinely improve lining in difficult cases, worth considering if nothing else works.





Comments